iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. iRhythm Technologies, Inc. is not a good growth stock. iRhythm Technologies, Inc. is not very popular among insiders. iRhythm Technologies, Inc. is a mediocre stock to choose.
Log in to see more information.
iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the de...
IRTC Fundamental Data by TradingView

News

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

Globe Newswire Zio ECG monitoring system is the only fourteen-day cardiac monitoring service in its category to receive Japanese regulatory approval as an improved device without a clinical trialZio ECG monitoring...\n more…

iRhythm Technologies (NASDAQ:IRTC) vs. Vapotherm (NYSE:VAPO) Head-To-Head Analysis
iRhythm Technologies (NASDAQ:IRTC) vs. Vapotherm (NYSE:VAPO) Head-To-Head Analysis

Ticker Report iRhythm Technologies (NASDAQ:IRTC - Get Free Report) and Vapotherm (NYSE:VAPO - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on...\n more…

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

Globe Newswire iRhythm granted exclusive license to BioIntelliSense's patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM...\n more…

iRhythm Technologies announces results of GUARD-AF trial
iRhythm Technologies announces results of GUARD-AF trial

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

iRhythm Technologies Announces Results of GUARD-AF Trial
iRhythm Technologies Announces Results of GUARD-AF Trial

Globe Newswire GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024Leveraging iRhythm's Zio patch-based long-term continuous monitoring (LTCM), GUARD-AF is the largest randomized...\n more…

iRhythm Technologies (NASDAQ:IRTC) Stock Rating Lowered by StockNews.com
iRhythm Technologies (NASDAQ:IRTC) Stock Rating Lowered by StockNews.com

Ticker Report iRhythm Technologies (NASDAQ:IRTC - Get Free Report) was downgraded by equities researchers at StockNews.com from a "hold" rating to a "sell" rating in a note issued to investors on Friday. IRTC has...\n more…